1st Quarter - Report

RED+BLUE STRATEGIES for PEW CHARITABLE TRUSTS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Regulatory issues surrounding unique device identifiers (UDI) being addressed by CMS, FDA and ONC. Regulatory issues related to Meaningful Use 3 as it could related to the utilization of UDIs. Exploring new policies to improve end of life care in America. Issues related to ending prescription drug abuse and diversion in Medicare and Medicaid.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Health Issues HCR

S. 633 - The Promise for antibiotics and Therapeutics for Health (PATH) Act - Focused on ensuring that the Food and Drug Administration has the necessary to tools to ensure that medically needed antibiotics are made available to the public. Regulatory issues surrounding unique device identifiers (UDI) being addressed by CMS, FDA and ONC. Regulatory issues related to Meaningful Use 3 as it could related to the utilization of UDIs. Exploring new policies to improve end of life care in America. Issues related to ending prescription drug abuse and diversion in Medicare and Medicaid. Advancing provisions to highlight Antibiotic Innovation in the President's FY 2016 budget.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 633 (114th)

Pharmacy PHA

S. 633 - The Promise for antibiotics and Therapeutics for Health (PATH) Act - Focused on ensuring that the Food and Drug Administration has the necessary to tools to ensure that medically needed antibiotics are made available to the public. Issues related to ending prescription drug abuse and diversion in Medicare and Medicaid. Advancing provisions to highlight Antibiotic Innovation in the President's FY 2016 budget.

LobbyistCovered position, as disclosed
MEGAN HAUCK MARSHALL —
MELANIE JAN NATHANSON —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 633 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.